Latest Simsen Diagnostics News & Updates
See the latest news and media coverage for Simsen Diagnostics. We track all announcements, press releases, and industry mentions in real time, all in one place.
Ultra-sensitive ctDNA analysis provider
simsendiagnostics.com- Headquarters
- Mölndal, Sweden
- Founded year
- 2020
- Company type
- Private company
- Number of employees
- 5–10
Latest news about Simsen Diagnostics
Company announcements
-
Simsen Diagnostics highlights ctDNA studies detecting relapses early
Studies using SiMSen-Seq detected ctDNA rises months before scans in rhabdomyosarcoma and neuroblastoma patients. They offer full-service monitoring and Personal LabSuite, seeking European partners.
-
Simsen Diagnostics partners with One-carbon Therapeutics for ODIN cancer trial
Simsen deploys Simsen® Personal to monitor ctDNA in the Phase 1/2 trial evaluating TH9619 for solid cancers. The collaboration aims to detect minimal residual disease and guide dosing.
-
Simsen Diagnostics announces hospital laboratory solution
Partners with Swedish hospital for tumour-informed ctDNA analysis. Provides panels, reagents, and support for seamless integration, efficiency, and precision oncology.
-
Simsen Diagnostics announces collaboration with Buzzard Pharmaceuticals
Simsen partners for ultrasensitive ctDNA analysis in Buzzard's Phase IIa colorectal cancer trial using SiMSen-Seq platform. CEOs express enthusiasm.
Media coverage
Track Simsen Diagnostics and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Simsen Diagnostics competitors & trending companies
Browse news for competitors to Simsen Diagnostics and other trending companies.
Biovica
Sironax
Aperture Therapeutics
Attentive
Klaviyo
Twilio
Insider One
Zeta Global
Iterable
Braze
Optimove
Bluecore
BlueConic
Amperity
Wero
BLIK
EPI
Swish
Affirm
Brite Payments
TCS
Overview Energy
Adfin
Ineffable Intelligence
Mechanize
Hexatronic
Alimak Group
Lindab Group
NYAB
Noon Energy
Nordan AI
Mips
Vexlum
Asker Healthcare Group